GODREJAGRO Godrej Agrovet Q1 FY26 results (Apr–Jun 2025) and concall
Godrej Agrovet started FY26 on a strong note, with double-digit growth in revenue and profits, primarily driven by an exceptional performance in the Vegetable Oil segment and a significant turnaround in Astec LifeSciences. However, the quarter also highlighted challenges, with the Crop Protection business facing weather-related headwinds for its key herbicide products and the Dairy segment experiencing margin pressure from rising costs. The core Animal Feed business demonstrated robust volume demand, but pricing power remains a key monitorable. Management's focus is clearly on portfolio premiu
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 1,848 | 1,869 | 1,550 | 2,007 |
| EBITDA | 222 | 195 | 130 | 259 |
| Net profit | 132 | 166 | 68 | 169 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
